Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel

被引：0
|
作者：
Roberta Galeazzi
Fabiola Olivieri
Liana Spazzafumo
Giuseppina Rose
Alberto Montesanto
Simona Giovagnetti
Sara Cecchini
Gelsomina Malatesta
Raffaele Di Pillo
Roberto Antonicelli
机构：
[1] INRCA National Institute,Clinical Laboratory and Molecular Diagnostics
[2] DISCLIMO,Department of Clinical and Molecular Sciences
[3] Università Politecnica delle Marche,Center of Clinical Pathology and Innovative Therapy
[4] INRCA National Institute,Center of Biostatistics
[5] INRCA National Institute,Department of Biology, Ecology and Earth Sciences
[6] University of Calabria,Unit of Radiology
[7] National Institute of Health and Science on Aging (INRCA),Cardiology Unit
[8] National Institute of Health and Science on Aging (INRCA),undefined
来源：
Drugs & Aging | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 656
页数：7
相关论文
共 50 条
  • [1] Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel
    Galeazzi, Roberta
    Olivieri, Fabiola
    Spazzafumo, Liana
    Rose, Giuseppina
    Montesanto, Alberto
    Giovagnetti, Simona
    Cecchini, Sara
    Malatesta, Gelsomina
    Di Pillo, Raffaele
    Antonicelli, Roberto
    DRUGS & AGING, 2018, 35 (07) : 649 - 656
  • [2] The experience of the antiplatelet therapy by clopidogrel in the West-Siberian region of Russia: the effects of CYP2C19 and ABCB1 allelic variants
    Knauer, N.
    Voronina, E.
    Lifshits, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 628 - 628
  • [3] The role of CYP2C19 and ABCB1 polymorphisms on platelet reactivity during dual antiplatelet therapy
    Hou, X.
    EUROPEAN HEART JOURNAL, 2015, 36 : 230 - 231
  • [4] CYP2C19, ABCB1 and PON1 polymophisms in Chinese patients with acute coronary syndrome
    Liang, Y.
    Feng, G. X.
    Chen, T.
    Bai, Y.
    Liu, X.
    Yang, Y. M.
    Wang, X. Y.
    Yang, Y. J.
    Zhu, J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 1079 - 1079
  • [5] Genetic polymorphisms of CYP2C19*2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome
    Wang, Xia-qin
    Shen, Chen-lin
    Wang, Bang-ning
    Huang, Xiao-hui
    Hu, Zhang-le
    Li, Jun
    GENE, 2015, 558 (02) : 200 - 207
  • [6] Genetic variants besides CYP2C19*2 polymorphism are associated with major adverse cardiovascular events in high risk vascular patients on dual antiplatelet therapy
    Giusti, B.
    Saracini, C.
    Vestrini, A.
    Magi, A.
    Marcucci, R.
    Rossi, L.
    Cordisco, A.
    Nanna, C.
    Gensini, G. F.
    Abbate, R.
    EUROPEAN HEART JOURNAL, 2010, 31 : 156 - 156
  • [7] Financial Analysis of CYP2C19 Genotyping in Patients Receiving Dual Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention
    Johnson, Samuel G.
    Gruntowicz, Don
    Chua, Theresa
    Morlock, Robert J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (07): : 552 - 557
  • [8] Screening methods using clopidogrel by genotyping CYP2C19 cytochrome and ABCB1 gene in patients with acute coronary syndromes.
    Costache, Irina-Iuliana
    Aprotosoaie, Ana Clara
    Ivanov, Iuliu Cristian
    Iliescu, Dan
    Girleanu, Irina
    Petris, Antoniu Octavian
    BIOMEDICAL RESEARCH-INDIA, 2015, 26 (02): : 266 - 272
  • [9] Genetic polymorphisms of CYP2C19*2 and ABCB1 C3435T affect the pharmacokinetics and pharmacodynamics response to clopidogrel in patients with acute coronary syndrome in the Chinese Han population
    Wang Xiaqin
    Wang Bangnin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C127 - C128
  • [10] CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment
    Hou, Xumin
    Han, Wenzheng
    Gan, Qian
    Liu, Yuan
    Fang, Weiyi
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (05)
12345